Detlef S.
- Country
- Germany
- Department
- Institut für Translationale Immunolgie
Research Overview
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ANB033 in Patients with Celiac Disease
- Efficacy and Tolerability of ZED1227 in Patients with Celiac Disease Experiencing Symptoms Despite a Gluten-Free Diet: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial
- Efficacy and Safety of Subcutaneous Amlitelimab in Adults with Non-Responsive Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 2a/b Study
Data & Insights
Has run more than one trial at 12 of 97 partner sites.
Specializations
Gastrointestinal Disorders
This investigator specializes in the treatment of celiac disease, with particular focus on patients experiencing persistent symptoms despite dietary interventions.
- Non-responsive celiac disease management
- Gluten-free diet optimization
- Intestinal mucosal health
The research encompasses therapeutic approaches for improving intestinal function in celiac patients.
Therapeutic Innovation
The investigator explores novel therapeutic compounds for treatment-resistant celiac disease, including emerging pharmaceutical interventions.
- Innovative drug development
- Symptom management strategies
- Mucosal healing approaches
Research focuses on developing solutions for patients with persistent symptoms despite standard treatments.
Clinical Assessment
Expertise in evaluating celiac disease symptoms and treatment outcomes using specialized assessment tools and clinical measurements.
- Symptom evaluation methods
- Treatment response monitoring
- Clinical outcome assessment
The work involves comprehensive evaluation of therapeutic interventions in celiac disease treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.